Genetic Analysis of Complex Diseases

TECHNICAL COMMENTS
REFERENCES AND NOTES
Neil Risch, in a series of seminal papers in 1990 (1, 2) , demonstrated the utility of sibpair linkage analysis in identifying genes for complex genetic traits. In doing so, he defined what is the current paradigm for the genetic dissection of common complex genetic diseases. The recent Perspective by Risch and Kathleen Merikangas (3) again shapes the future of human disease gene mapping by defining what will undoubtedly become the statistical "state of the art." Risch and Merikangas advocate conducting genomic screens based on association studies of candidate genes using the transmission disequilibrium test (TDT). It is important, however, not to infer from their arguments that current linkage analysis methods cannot detect most genes underlying complex disease.
Risch and Merikangas extend the current paradigm to include anticipated technological advances. However, the magnitude of~(defined as the relative risk in the heterozygote) in complex traits and the application of this approach using current molecular technology must be considered.
In their formulation, Risch and Merikangas show that a TDT approach is more powerful than a sib pair approach, particularly for disease alleles with small genetic effects. This conclusion is based on the sample size required to detect a gene with a~:::; 4. They show that, while sib pair analysis requires a practical (for example, 100 to 400) number of sib pairs to detect a gene with~= 4 and a disease allele frequency p, between 0.1 and 0.5, the number of sib pairs required becomes impractical (for example, more than 1000) when~:::; 2.
Previously, Risch (1, 2) established the use of a sibling recurrence risk ratio (As) to estimate the power of a sib pair design to detect linkage. Estimable from epidemiologic data, As is calculated as the ratio of the recurrence risk in siblings of an affected individual and the population prevalence of the disorder. This As represents the overall recurrence risk ratio, which may result from the actions of a single gene or multiple genes acting additively or epistatically. If a number of genes are hypothesized, the genespecific As (referred to here as A gs ) may be estimated by assuming a model (additive or epistatic), the number of genes, and partitioning As accordingly.
Many researchers are accustomed to evaluating the magnitude of genetic effects by using As rather than~. We calculated A gs corresponding to~:::; 2 and p = 0.01,0.10,0.5, and 0.8, respectively. The results indicated that for~:::; 2, A gs < 1.3.
It has previously been shown that genes with A gs < 1.3 would be difficult to detect using sib pair methods (2, 4) . The curve comparing A gs with~shows that even genes with moderate effect (for example, A gs < 2) may produce~that can be detected by linkage analysis in reasonably sized samples of sib pairs.
These results indicate that linkage analysis of complex disease based on genomic screens using current microsatellite markers can be a fruitful enterprise in complex genetic diseases. An excellent example is the discovery of the late onset Alzheimer's disease susceptibility gene APOE. Using Risch and Merikangas's formulas, we calculated the number of sib pairs that would have been necessary to detect the effect of APOE on the risk of AD. The~in individuals heterozygous for APOE-4 is 4.5 (5) and the frequency of APOE-4 in the general population is about 15% (6); the resulting probability of allele sharing is Y = 0.625, and the minimum number of affected sib pairs required to detect linkage is 164. Alzheimer's disease has an overall As of 5, with a A gs of only 2 for APOE (7) . Other complex diseases, such as multiple sclerosis (As = 30) (8) and autism (As = 150) (9) have substantial genetic components. Even if there are 10 epistatic genes of equal multiplicative effect underlying multiple sclerosis (As = 30; A gs = 1.4), linkage analysis should be able to detect them. Because it is difficult to determine a priori which disease alleles have minor or moderate genetic effects, linkage analysis should not be arbitrarily abandoned.
Risch and Merikangas point out that genomic screening of candidate genes is several years from becoming reality. When the molecular resources become available, the advantages of genomic screening using TDT, such as increasing power to detect minor genetic effects, allowing the use of singleton cases, and testing effects of functional polymorphisms in genes, will luake this the method of choice. Until then, well-designed linkage studies of cOluplex traits will still be able to detect genes of major or moderate effect.
Risch and Merikangas (1) point out the efficiency of association studies for statistical power in identifying genetic luarkers of disease. But they liluit themselves to studies of faluily-based association, affected sibpairs, and parental transluission of alleles and do not mention population-based association studies (either cohort or case-control). While family-based association studies do have certain strengths, populationbased studies can be far more efficient in terms of time, money, and logistics. It can take much longer to identify and collect samples from a single affected family than to collect samples from 10 or 100 patients with disease. Some studies, such as those of parental transmission, may not be practical in adult onset diseases where parents are deceased. Such practical issues, as well as our ability to generalize the results to the larger population, favor the use of population-based studies.
Perhaps as important, population-based studies commonly measure environluental exposures and can assess gene-environluent interaction, data for which are nearly always lacking in family-based studies. An association between a susceptibility gene and a disease ll1ay not be apparent if there is a second factor required to initiate the disease process, such as an environmental exposure. Similarly, one luay detect the effect of exposure only among genetically susceptible subpopulations. There are a number of neurologic and other diseases in which this model functions, but the cases of genes that modulate carcinogen-induced cancers (such as the polymorphic glutathione S-transferases and N-acetyltransferases) are perhaps the best examples (2) . Siluple tests of gene-disease association are likely to be misleading without due attention to environmental factors. we can show that, when the disease is relatively comiuon, the disease-allele frequency is interlllediate and its effect siuall, statistical power cOiuparable to that of standard faniily-based linkage studies is achieved with a siualler number of randoiuly saiupled individuals. The saiuple sizes required for the disequilibriuiu iuethod are generally larger than those for transiuissiondisequilibriulll, but the randoiu-ascertainiuent scheiue has practical advantages. If one aSSUllles that 'IT is the probability that an individual with genotype aa has the disease, with Aa and AA individuals being, respectively,~and~2 iuore likely to develop the disease than aa individuals, one can show the expected frequencies of four categories defined by allelic state and disease status in a randolll population saiuple (2) . The association between iuarker allele A and disease can be tested with the "chisquare" statistic. The saiue statistic can be used to calculate saiuple sizes needed to detect such an association, if indeed it exists, with a given significance level and power, for fixed values of 'IT,~, and p, respectively (3). When the prevalence of the disease is greater than about 5% and the disease allele is not rare, the random sample approach requires no iuore than 10 tilues the nUiuber of genotyped individuals in an affected offspring study (4) . Once genotyped, the saiue saiuple can be used to study a nUiuber of diseases for the additional, siuall cost of ascertaining the presence or absence of a disease in each individual. The randoiu sample approach could be especially useful for efficiently diagnosed late onset diseases, where it iuay not be possible to type parents for affected offspring studies. Non-insulin-dependent diabetes and hypertension, with prevalences of 6% (5) and 23 % (6) , respectively, could be effectively studied using this approach.
A realistic program for iuapping disease markers using the randoiu-ascertainiuent scheiue may require a prospective design in which a cohort is fully genotyped and iuonitored for disease. The successes of the Fraiuinghaiu Study (7) and others like it show that large-scale prospective studies are not beyond reach. The effort required to genotype a large sample at iuany iuarker loci seems formidable, but the autoiuated iuethods envisioned by Risch and Merikangas greatly reduce the labor for the randomascertainment scheme as well. The utility of both approaches depends on the existence of marker alleles strongly associated with disease-causing polymorphisius, but as yet the nature and extent of such associations in the human genome are not well understood (8) . Population structure (the result of admixture or other factors) introduces cOiuplications for simple disequilibriuiu methods that are iuinimized in family-based transmission-disequilibrium studies (9) . However, if study populations are defined carefully and data are examined for the effects of population structure, these difficulties iuay be balanced by gains in efficiency that accrue when a single large sample is used to study several diseases. Risch and Merikangas (1) show the great power of genetic association studies such as the TDT in the detection of genes with iuodest effects. As they iuention, all TDT computations were based on the optimal assumption that the analyzed allele was the disease allele itself. A more COiumon situation is, and could well remain, the analysis of polymorphisius which have a low prior probability to be the disease allele even if they are within the actual disease gene. The power of the TDT is highly dependent not only on the linkage disequilibriuiu between the disease allele and the analyzed allele but also on the relative frequencies of both these alleles. decreases. Thus, the power of association studies such as the TDT can be quite strong \\Then there is a high probability that the allele studied is the causal allele as shown by Risch Response: We agree with Scott et al. that linkage analysis will be able to identify genes of iuajor, but not genes of modest, effect. As such, we also agree that linkage analysis should not be arbitrarily abandoned, because undoubtedly it will lead to the discovery of some iiuportant disease susceptibility genes. However, we do not agree that linkage analysis can detect iUOSt genes underlying cOiuplex diseases, and we anticipate that few genes for cOiuplex disorders will be identified in this fashion.
Anthony
As indicated by Scott et al., one iueasure of the total genetic effect for a cOiuplex disease is As' the sibling risk ratio (1 ). However, it is generally impossible to detenuine the nUiuber of loci contributing to that total; if the number is large, even for a large value of As' then none of the loci iuay be easily detected by linkage analysis. We showed in our Perspective (2) that loci which confer a genotypic relative riskl ess than 4 would be difficult or impossible to identify with current linkage strategies. The numbers of sib pairs required to detect linkage that were given in the table in our Perspective (2, p. 1516) were actually underestimates, for two reasons: (i) There was an error in the COiuputer prograiu producing the required number of sib pairs for linkage; the actual nUiubers are approximately 50% larger than given (3); and (ii) the nUiubers given correspond to the ideal case of COiUpletely infonuative markers and no reCOiUbination.. Allowing for iuore realistic circumstances of reduced iuarker infonuativity and moderate recoiubination, the corrected nUiubers probably would be about two to three times larger than given in the table. Thus, while it is still possible to detect a locus with~of 4 or greater in a large faiuily collection (say 500 or iuore), loci with smaller values of~are unlikely to be detected.
How iuany loci are likely to exist for complex diseases with~> 4? While it is difficult to know beforehand, anilual iuodels might offer a clue. As an exaiuple, the non-obese diabetic (NOD) lllouse provides a useful model for hUiuan insulin dependent diabetes iuellitus in being genetically complex, having an autoilumune etiology, and in the iluportance of the iuajor histocoiupatibility 10cL However, backcross experiiuents have shown that at least 10 other loci are probably involved in susceptibility, and only one of these loci had a value ofg reater than 4, with the rest in the range of 2 or less (4) . We also note that anilual backcross experiluents are iuore analogous to human association studies than linkage studies, and this is why they have been more successful in identifying susceptibility loci than hUiuan linkage studies.
As indicated by Scott et al., multiple sclerosis is a cOiuplex disease with a presluued substantial genetic cOiuponent (5). However, three recently published genome screens (6) of iuoderate size did not produce clear and replicable evidence of linkage in
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any chroiuosoiual region. This lack of susceptibility loci of large effect in this disease suggests that a very large nUiuber of faiuilies iuay be required to detect linkage.
The discovery of apoE as a iuajor risk factor for late onset Alzheiluer's disease is surely one of the major success stories of iuodern hUiuan genetics. Thus, it is iiuportant to evaluate the iueans by which this discovery was made. As indicated by Scott et al., it has been estiluated that apoE confers a As value of around 2, with SOlue modification for age of onset (7) . Thus, in theory, this locus would be identifiable by linkage analysis \vith a sufficient nUiuber of sib pairs (several hundred miniluuiu). In fact, the initial linkage observation on chro1l10soiue 19 (8) , which produced a lod score of 4, was based on an analysis with 111arkers that were likely to be in linkage disequilibrium with apoE. Perfonuing linkage analysis with a marker associated with disease leads to an increase in the lod score (9) . Siluilar linkage analysis with a nearby iuarker with little or no linkage disequilibriuiu (for exaiuple, the apo ell iuicrosatellite) in the saiue iuaterial does not produce significant evidence for linkage (8, 10) . Thus, in reality, the "linkage" discovery on chrolllosoiue 19 was actually based on an association between lllarker loci and the disease.
We agree with Scott et al. that genomewide association studies will be based on future rather than current technology (as indicated in our title), and for the present we are stillliiuited to the technology that exists. Although we agree that linkage studies should continue to be pursued, we also believe that this approach will produce only a iuodest nUiuber of loci for cOiuplex diseases.
We agree with Bell and Taylor that candidate genes are best tested in the fraiuework of a biological hypothesis, often involving an interaction with a predisposing environiuental agent, and the exaiuples they provide are illuiuinating [for others, see (11 ) ]. Also, as they point out, classic epidemiologic study designs, such as casecontrol or cohort, are excellent for testing such gene-environiuent interaction effects. The priluary drawback froiu such designs for detecting genetic effects, however, is the potential for confounding, leading to an incorrect inference of causality for an observed association (12) . Specifically, consider a population that has ethnic stratification and a tendency toward endogaiuy within strata. Further suppose these strata differ both in disease prevalence and allele frequencies at an unrelated locus. When performing a case-control study from such an adiuixed population, if the cases and controls are unbalanced for these strata, an allele frequency difference between cases and controls iuay eiuerge which is artifachttp://www.scienceiuag.org • SCIENCE • VOL. 275 • 28 FEBRUARY 1997 tual and not causal. The solution, of course, is to precisely iuatch the cases and controls according to these strata, or to perfonu a stratified analysis; such would be possible with the iuajor ethnic groups such as exist in the United States. However, further strata are likely to exist \vithin the iuajor ethnic groupings (for exaiuple, European subgroups of Caucasians) for which iuatching and stratification might generally be quite difficult. Of course, this probleiu disappears in a completely randoiuly iuating population.
This probleiu can also be solved by resorting to faiuily-based association tests, such as the TDT we used in our analysis. This test has been shown to be iiUiuune to confounding due to population stratification (13) . Also, in the absence of population stratification, this test has similar PO\v-er to the usual case-control design (14) . Furthenuore, cases or families (or both) can also be classified according to a relevant environmental exposure and allelic transiuission cOiupared across these classes to search for gene-environment interactions. We also showed that unless the disease predisposing allele frequency is high, faiuilies with iuore than one affected child can be substantially iuore powerful than singletons, although they are also likely to be more difficult to find.
Because of the potential problen1 of genetic stratification, the optin1al design for searching for genes of 1110dest effect, especially in the absence of a clear biological model, is the faiuily-based design, such as singleton or multiple affected sibs with parents. For early onset diseases, such sa1l1ples should not be difficult to obtain, and are likely worth the potential additional cost. We would add that precise ethnic iuatching in a case-control paradigiu can also lead to increased expense, if achievable at all. In the situation of late onset diseases, where parents are usually unavailable, an alternative design is discordant sib pairs, where effectively an unaffected sib serves as a control for the affected sib. This design also protects against genetic stratification artifact, but may lead to sOluewhat reduced power because of the genetic correlation between sibs (14).
Long et al. suggest a prospective study design where a random population saiuple is subsequently followed for developiuent of disease. Presumably, at initiation, everyone in the study is genotyped for a large nllluber of loci. They show that if the disease is sufficiently COiumon, reasonable power is obtained by contrasting the allele frequencies in those who develop the disease with those that do not. The prin1ary benefit fron1 this approach is that multiple diseases can be studied using the saiue population of subjects, again provided the diseases are sufficiently COiUiuon. It \vould appear that a miniiUUiU frequency of 10% is required to obtain plausible saiuple sizes for sufficient power.
There are also several drawbacks to this approach. First, as for the typical epideiuiologic paradigms, such as case-control studies, there is the probleiu of population substructure as we have described (in our response to Bell and Taylor) and also iuentioned by Long et al. Second, with this approach, sample pooling is not possible, because it is unknown a priori which individuals will beCOiue affected. Thus, this approach requires construction of individual genotypes, which can greatly iuagnify the technical effort. By contrast, for a typical case-control design, two pools can be fonued-one for affected individuals, another for those unaffected, and overall allele frequencies within the two groups determined. Thus, for a study of n cases and n controls and t loci, genotypes for only 2t saiuples need to be detenuined as opposed to 2nt samples (15) . The same efficiency iuay obtain for a family-based design, such as affected individuals and their parents, where those affected are pooled and contrasted to the pooled group of parents. While this approach cannot give the precise data needed for a TDT analysis, it still provides a robust, powerful, and efficient iueans for initial screening; any positive loci can subsequently be subjected to individual genotyping (14) .
The approach of Long et al. would not be practical for rare diseases, for exa1l1ple, those with a population frequency less than 50/0. However, a comproiuise is possible. Numerous studies already exist that sample affected individuals, with parents or unaffected sibs, for a variety of diseases. The subj ects fro1l1 these studies can be followed for a variety of other diseases and then subjected to analysis as they develop these other, iuore frequent diseases. Pooling across studies could then provide sufficient 111aterial.
As indicated by Miiller-Myhsok and Abel, our analysis was based on association studies where the actual disease predisposing polYiuorphisiu is in hand. This is why we incorporated such a large nUiuber of tested alleles (1,000,000). We also indicated that the nUiuber of loci to be tested might be reduceable substantially if one allows for linkage disequilibrilllu. However, as pointed out by Muller-Myhsok and Abel, depending on linkage disequilibrilllu is not without risk. The power of the association test can decline dra1l1atically as linkage disequilibriu1l1 diiuinishes or if the tested allele has a substantially different frequency than the disease allele. To a large extent, the expectation with regard to linkage disequilibriuiu across the genoiue is uncharted territory, and thus it is difficult to predict the power of using a less dense map at this point in time. However, we can present two cases that provide SOlue degree of optiluism. The first pertains to apoE and late onset Alzheimer's disease. Several polymorphisius in the apoE region show strong linkage disequilibrium and comparable allele frequencies, allowing association to be readily detected with other neighboring polYiuorphisms (16) . A second example is the insulin VNTR region of chromoSOlue 11p. Several polymorphisms in this region have been identified showing strong disequilibriuiu and siiuilar allele frequencies, leading to comparable degrees of association with disease (17) .
As genome-wide linkage studies are supplanted by genoiue-wide association studies, and the distribution of linkage disequilibrium across chromosoiues and populations is further explored, the degree to which link
